Last reviewed · How we verify
NCT04910724
Effects of Varying Energy Deficits on Protein Turnover at Rest and Carbohydrate Oxidation During Steady-state Exercise
NA trial testing Energy Deficit in Energy Supply; Deficiency, Severe in 30 participants. Completed in 7 March 2024.
7 March 2024
Quick facts
| Lead sponsor | United States Army Research Institute of Environmental Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 30 |
| Start date | 16 August 2022 |
| Primary completion | 7 March 2024 |
| Estimated completion | 7 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Energy Deficit
Conditions studied
- Energy Supply; Deficiency, Severe — all drugs for Energy Supply; Deficiency, Severe →
- Energy Supply; Deficiency — all drugs for Energy Supply; Deficiency →
- Stress, Physiological — all drugs for Stress, Physiological →
Sponsor
United States Army Research Institute of Environmental Medicine
Who can join
Adults 18 to 35, any sex, with Energy Supply; Deficiency, Severe or Energy Supply; Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized, parallel study will examine the effects of energy balance and varying magnitudes of energy deficit on 1) the protein kinetic responses to consuming high quality protein and 2) carbohydrate oxidation during steady-state exercise. Healthy adults, representative of active duty military personnel, will complete a 2 d energy balance phase followed by a randomly assigned, 5 d energy deficit phase (n=15 per group; 20%, 40% and 60% energy deficit). At the end of each energy phase the effects of energy balance and energy deficit severity on resting postabsorptive (fasting) and postprandial (after consuming \~34 g protein) muscle protein synthesis (MPS) and whole-body protein synthesis, breakdown, and balance (synthesis - breakdown) will be determined. On the next day, the effects energy balance and energy deficit severity on carbohydrate oxidation during steady-state exercise will be determined. Primary study procedures include anthropometric and body composition measures, resting metabolic rate measures, aerobic exercise, tightly controlled diet and exercise interventions, repeated blood sampling, stable isotope infusion, stable isotope ingestion, and percutaneous muscle biopsies. The following hypotheses will be tested: 1) Δ (postprandial - postabsorptive) MPS and Δ whole-body protein balance at rest will progressively decrease as magnitude of energy deficit increases and 2) exogenous carbohydrate oxidation will be higher and endogenous carbohydrate oxidation will be lower during steady-state exercise as magnitude of energy deficit increases.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04910724
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Energy Deficit
Trials testing the same drug.
- NCT05203133 — Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality · NA · completed
Other United States Army Research Institute of Environmental Medicine trials
Trials by the same sponsor.
- NCT07489690 — Energy Dense Fueling for Cold-Weather Operations · NA · recruiting
- NCT07099872 — Chronic Exercise With Overdressing · NA · completed
- NCT06468748 — The Effects of Semaglutide on Body Composition and Performance in Military Personnel · Phase 4 · withdrawn
- NCT07063173 — Bioavailability of Ration Items Containing Tart Cherry Extract · NA · recruiting
- NCT06073080 — Recovery Protein Nutrition as a Countermeasure for Anabolic Resistance Following Sleep Loss · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04910724 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by United States Army Research Institute of Environmental Medicine
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04910724.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing